Aguirre M, Collins MD. Lactic acid bacteria and human clinical infections. J Appl Bacteriol 1993;75:95-107.

Armuzzi A, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001;15(2):163-169.

Arvola T, et al. Prophylactic lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999;104(5):1-4.

Beachey EH. Bacterial adherence. London: Chapman and Hall, 1980.

Bengmark S. Pre-, pro- and synbiotics. Curr Opin Clin Nutr Metab Care 2001;4(6):571-9.

Bernet MF, Brassart D, Neeser JR, Servin AL. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol 1993;59:4121-31.

Coconnier MH, et al. Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 1997;41:1046-52.

Conway PL, Blomberg L. Reduction in incidence and severity of diarrhoea in soldiers consuming Lactobacillus fermentum KLD. Publication in preparation (in file), 2002.

Freter R. Factors affecting the microecology of the gut. In: Fuller R, ed. Probiotics, the scientific basis. London: Chapman & Hall, 1992: 111-44.

Gibson SAW, Conway PL. Recovery of a probiotic organism from human faeces after oral dosing. In Human Health: The contribution of microorganisms in Springer Series in Applied Biology, 1994, pp. 119-143.

Gionchetti P, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial. Gastroenterol 2000;119:305-9.

Gopal PK, et al. In vitro adherence properties of Lactobacillus rhamnosus DR20 and Bifidomacterium lactis DR10 strains and their antagonistic activity against an enterotoxigenic Esherichia coli. Int Food Microbiol 2001;97(3):207-216.

Gupta P, et al. Is Lactobacillus AG helpful in children with Crohn’s disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 2000;31:453-7.

Havenaar R, Huis In’t Veld MJH. Probiotics: a general view. In: Lactic acid bacteria in health and disease. Volume 1. Amsterdam: Elsevier Applied Science Publishers, 1992.

Holzapfel WH, Haberer P, et al. Overview of gut flora and probiotics. In J Food Microbiol 1998;41:85-101.

Hudault S, et al. Antagonistic activity in vitro and in vivo exerted by lactobacillus casei (strain GG) against Salmonella typhimurium infection. Appl Environ Microbiol 1997;63:513-518.

Isolauri E, et al. Probiotics in the management of atopic eczema. Clin Exp Allergy 2000;30:1605-10.

Isolauri E, et al. Probiotics: effects on immunity. Am J Clin Nutr 2001;73(suppl):444S-50S.

Joint FAO/WHO Expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Córdoba, Argentina. October 1-4, 2001.

Kaila M, et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human lactobacillus strain. Pediatr Res 1992;32:141-4.

Kalliomaki M, et al. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 2001;357:1076-9.

Li P, Conway PL. Effects of administration of Lactobacillus fermentum on faecal microbes and symptoms in patients with irritable bowel syndrome. Publication in preparation (in file), 2002.

Mackie R, Gaskins HR. Gastrointestinal microbial ecology. Science & Medicine, Nov/Dec 1999.

Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol 1997;99:179-86.

Marteau P, Rambaud JC. Probiotiques en gastroenerologie: bases rationelles, effet demontres et perspectives. Hepato-Gastro 1998;5:267-273.

Marteau PR, et al. Protection from gastrointestinal disease with the use of probiotics. Am J Clin Nutr 2001;73(suppl):430S-6S.

Metchnikoff E. Lactic acid as inhibiting intestinal putrefaction. In” The prolongation of life: optimistic studies. W. Heinemann, London, pg. 161-183. 1907.

Mitsuoka T. Intestinal flora and ageing. Nutr Rev 1992;50:438-46.

Naidu AS, Biblack WR, Clemens RA. Probiotic spectra of lactic acid bacteria (LAB). Crit Revs Food Sci & Nutr 1999;(39):13-126.

Ogawa M, et al. Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli 0157:H7 infection in infant rabbits. Infect Immun 2001;69:1101-8.

Ouwehand AC, Kirjavainen PV, Grönland MM, Isolauri E, Salminen SJ. Adhesion of probiotic micro-organisms to intestinal mucus. Int Dairy J 1999;9:623-30.

Perdigon G, et al. Effect of perorally administered lactobacilli on macrophage activation in mice. Infect Immun 1986;53:404-10.

Plant L, Conway PL. Association of Lactobacillus spp with Peyers Patches in mice. Clinical and Diagnostic Immunology 2002;8(2):320-324.

Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001:73(suppl):437S-43S.

Savage DC. Associations and physiological interactions of indigenous microorganisms and gastrointestinal epithelia. Am J Clin Nutr 1972;25:1372-9.

Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics – approaching a definition. Am J Clin Nutr 2001;73(suppl):361S-4S.

Shanahan F. Probiotics and inflammatory bowel disease: Is there a scientific rationale? Inflamm Bowel Dis 2000;6:107-15.

Tannock GW. Analysis of the intestinal microflora: A renaissance. Antonie van Leenwenhoek 1999;76:265-278.

Welin A, Farthing M, Conway PL. Colonization of ileal mucosa by Lactobacillus fermentum KLD in pouchitis patients after oral dosage. Publication in preparation (in file), 2002.